197 related articles for article (PubMed ID: 19156147)
1. Frequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulation.
Rahman MM; Qian ZR; Wang EL; Sultana R; Kudo E; Nakasono M; Hayashi T; Kakiuchi S; Sano T
Br J Cancer; 2009 Feb; 100(3):501-10. PubMed ID: 19156147
[TBL] [Abstract][Full Text] [Related]
2. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
3. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
De Martino M; Pellecchia S; Esposito F; Tosti N; Quintavalle C; Eppenberger-Castori S; Carafa V; Righi A; Chieffi P; Fusco A; Terracciano LM; Pallante P
Cell Cycle; 2022 Jun; 21(12):1335-1346. PubMed ID: 35282770
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
5. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of high mobility group A proteins in lung cancer.
Sarhadi VK; Wikman H; Salmenkivi K; Kuosma E; Sioris T; Salo J; Karjalainen A; Knuutila S; Anttila S
J Pathol; 2006 Jun; 209(2):206-12. PubMed ID: 16521118
[TBL] [Abstract][Full Text] [Related]
7. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
Sampedro-Núñez M; Luque RM; Ramos-Levi AM; Gahete MD; Serrano-Somavilla A; Villa-Osaba A; Adrados M; Ibáñez-Costa A; Martín-Pérez E; Culler MD; Marazuela M; Castaño JP
Oncotarget; 2016 Feb; 7(6):6593-608. PubMed ID: 26673010
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of HMGA1 and HMGA2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 320 gastroenteropancreatic neuroendocrine tumors identifies TS expression as independent biomarker for survival.
Lee HS; Chen M; Kim JH; Kim WH; Ahn S; Maeng K; Allegra CJ; Kaye FJ; Hochwald SN; Zajac-Kaye M
Int J Cancer; 2014 Jul; 135(1):128-37. PubMed ID: 24347111
[TBL] [Abstract][Full Text] [Related]
10. Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.
Panarelli N; Tyryshkin K; Wong JJM; Majewski A; Yang X; Scognamiglio T; Kim MK; Bogardus K; Tuschl T; Chen YT; Renwick N
Endocr Relat Cancer; 2019 Jan; 26(1):47-57. PubMed ID: 30021866
[TBL] [Abstract][Full Text] [Related]
11. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
12. Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.
Kleiman DA; Beninato T; Sultan S; Crowley MJ; Finnerty B; Kumar R; Panarelli NC; Liu YF; Lieberman MD; Seandel M; Evans T; Elemento O; Zarnegar R; Fahey TJ
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S672-9. PubMed ID: 24854489
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors.
Ceppi P; Volante M; Ferrero A; Righi L; Rapa I; Rosas R; Berruti A; Dogliotti L; Scagliotti GV; Papotti M
Clin Cancer Res; 2008 Feb; 14(4):1059-64. PubMed ID: 18281538
[TBL] [Abstract][Full Text] [Related]
14. The association of the angiopoietin/Tie-2 system with the development of metastasis and leukocyte migration in neuroendocrine tumors.
Figueroa-Vega N; Díaz A; Adrados M; Alvarez-Escolá C; Paniagua A; Aragonés J; Martín-Pérez E; Leskela S; Moreno-Otero R; González-Amaro R; Marazuela M
Endocr Relat Cancer; 2010 Dec; 17(4):897-908. PubMed ID: 20696814
[TBL] [Abstract][Full Text] [Related]
15. Hereditary neuroendocrine tumors of the gastroenteropancreatic system.
Anlauf M; Garbrecht N; Bauersfeld J; Schmitt A; Henopp T; Komminoth P; Heitz PU; Perren A; Klöppel G
Virchows Arch; 2007 Aug; 451 Suppl 1():S29-38. PubMed ID: 17684762
[TBL] [Abstract][Full Text] [Related]
16. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
[TBL] [Abstract][Full Text] [Related]
17. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
[TBL] [Abstract][Full Text] [Related]
19. Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation.
Martinez Hoyos J; Fedele M; Battista S; Pentimalli F; Kruhoffer M; Arra C; Orntoft TF; Croce CM; Fusco A
Cancer Res; 2004 Aug; 64(16):5728-35. PubMed ID: 15313913
[TBL] [Abstract][Full Text] [Related]
20. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
